New lens implant shows promise for cataract patients

NCT ID NCT05646004

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a new lens called 621 in 105 adults having cataract surgery. The lens was implanted during standard surgery to replace the cloudy natural lens. Researchers checked how well patients could see 6 months after surgery and monitored for any safety issues. The goal was to see if the lens is a safe and effective option for restoring clear vision.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

621 intraocular lens implant

What this could lead to

If successful, this lens could provide a safe and effective option for restoring vision after cataract surgery.

What could go wrong

This was a small, single-arm study with no comparison group. Long-term benefits and rare risks are not fully known.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SENILE CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

senile cataract

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.

Contacts and locations

Locations

  • Hainan Boao Lecheng Aier Eye Hospital

    Qionghai, Hainan, China